Australia's largest stock trading and investment forum Australia's #1 stock forum

ZNO

12.0%

2.8¢ zoono group limited

Fine Hygienic partnership with Zoono, page-2

First 2 Last

Share
Profile

Follow
Tarvold

22,879 Posts.

1259

25/11/20

08:51

Post #: 49120614
Share

Originally posted by Lilo88: ↑

This was mentioned in the AGM presentation. They have repacked ZNO products under their own label and will sell it in 70 countries.

It seems that this is potentially huge for ZNO with FHH well positioned as a global player in the personal hygiene market.

The fact that Zoono products are alcohol free so they can be Halal certified will make them the preferred products for all Muslim markets.

This is the wikipedia info on FHH:
Fine Hygienic Holding (Arabic: مجموعة فاين القابضة‎, abbreviated FHH), is a wellness company with dual headquarters in Amman, Jordan and Dubai, UAE, founded in 1958 by Elia Nuqul.[1] Its current CEO is James Michael Lafferty. FHH mainly specializes in the production of personal care and hygienic products, including sterilized facial tissues, kitchen towels and toilet paper, baby and adult diapers, as well as natural, healthy beverages after obtaining a majority stake in the Arabian natural food and beverage brand, Nai Arabia Food Co, and a recent addition of personal protective equipment (PPE). FHH employs over 3,500 people of more than 30 different nationalities, operating in Jordan, Egypt, Saudi Arabia, the UAE, and Morocco, and serves over 80 markets across the Middle East, Africa, Europe, Asia, and the USA.

This was published on their website November 16th:
FHH is taking germ protection to the next level with the new range. Fine Guard PureHands is a hand sanitizer which provides 24 hours protection with just one application and Fine Guard PureSurfaces is a surface disinfectant offering 21 days of protection. The new range is just part of an exciting pipeline of environmentally friendly products which provide protection against germs and pathogens.

FHH CEO James Michael Lafferty said: “At Fine Hygienic Holding we take our responsibility to our communities and wider society very seriously. This latest range of products is another line of defense that we are providing for the UAE market – from parents at home looking after their loved ones through to the workforce powering the economy, they can all take confidence in this new range.

Lafferty explained the benefits of the new products to households in the UAE. He said: “Many of today’s disinfectants stop working a matter of minutes after application. This dynamic creates little peace of mind and necessitates continual disinfection to ensure safety. Now with Fine Guard Technology, a consumer can “Fine Guard it and forget it,” and know their families are protected for an extended period of time. We are taking things to the next level in terms of performance and protection with these products.”

All products in the range incorporate an anti-viral technology from New Zealand which forms a long-lasting, non-toxic, antimicrobial coating that safely bonds to skin and protects against bacteria and viruses. All products are made in partnership with Zoono, a reputed international brand that develops, manufactures, and distributes a suite of proven, long lasting and environmentally friendly antimicrobial solutions.

Fine Guard PureHands is the only US FDA-approved hand sanitizer that is proven to kill 99.9% of germs and viruses and provides 24-hour protection with just one application. Alcohol and toxin-free, the product is 100% safe and suitable for adults and children, with dermatological testing proving it suitable for all skin types including delicate and sensitive skin.

Fine Guard PureSurfaces is the only surface disinfectant that provides a 21-day protection from germs and viruses. Clinical testing proved the product kills 99.9% of germs and viruses, and the alcohol-free, non-toxic spray is safe to use around food.

FHH already supports the UAE market through its extensive range of Fine Guard reusable masks and gloves which incorporate a Swiss textile tech, and other hygienic paper products including tissues, paper towels, nappies, and more.

Expand

In the 2019 AGM presentation ZNO said it would only enter into White Label deals for a minimum of $1m p.a.

ZNO Price at posting: $1.34 Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

There are more pages in this discussion • 21 more messages in this thread...

First 2 Last

Add ZNO (ASX) to my watchlist

(20min delay)
Last 2.8¢		Change 0.003(12.0%)		Mkt cap ! $9.952M

Open	High	Low	Value	Volume
2.6¢	2.8¢	2.6¢	$3.277K	117.0K

Buyers (Bids)

No.	Vol.	Price($)
2	65824	2.7¢

Sellers (Offers)

Price($)	Vol.	No.
2.9¢	304864	1

View Market Depth

No.	Vol.	Price($)
2	65824	0.027
3	249370	0.026
3	143409	0.025
1	154528	0.024
1	39000	0.023

Price($)	Vol.	No.
0.028	36240	1
0.029	304864	1
0.030	531000	3
0.031	32096	1
0.032	139295	2

Last trade - 14.07pm 07/10/2024 (20 minute delay)

ZNO (ASX) Chart

Fine Hygienic partnership with Zoono, page-2

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Fine Hygienic partnership with Zoono, page-2

Top Stories

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News